Policy and Advocacy
Taking the Pulse of PEPFAR
A new study by amfAR’s Public Policy Office documents how a withdrawal of U.S. funding for HIV services around the world is impacting the fight against AIDS.
When Grants End, So Do Scientific Breakthroughs
New analysis from amfAR’s Public Policy Office assesses the human cost of terminated federal research grants focused on cancer.
Your Source for HIV Data
amfAR maintains a series of free interactive databases to inform policymakers, public health officials, advocates, researchers, and other stakeholders about key aspects of the evolving U.S. and global HIV epidemics. These essential resources provide comprehensive data on global HIV programming/funding, key populations, the opioid epidemic, COVID-19, and the U.S. Ending the Epidemic plan.
For Long-Term Survivors, HIV Is Just a Piece of the Puzzle
amfAR Trustee Phill Wilson reflects on his journey living with HIV for over four decades—his personal losses, his HIV advocacy, and staying on top of his health as he ages.
New Agreements for Funding Global HIV Program Miss the Mark
A new amfAR report analyzes how the new Global Health MOUs fail to establish metrics to measure their success.
Ending AIDS Is at Risk.
A new report from UNAIDS details where and how the fight against AIDS is faltering due to funding cuts and how the HIV response can rebound.
amfAR at AIDS 2026: Rethink. Rebuild. Rise.
At AIDS 2026, the 26th International AIDS Conference, amfAR helps power a cutting-edge, collaborative response to HIV across research and advocacy.
Journal of the International AIDS Society Publishes amfAR Analysis of PEPFAR Program Data
amfAR’s Public Policy Office tracks changes in services and impacts to the HIV workforce following the U.S. foreign aid freeze.
Ending AIDS Is at Risk.
A new report from UNAIDS details where and how the fight against AIDS is faltering due to funding cuts and how the HIV response can rebound.